Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Clovis Oncology Inc (NASDAQ:CLVS)

23.15
Delayed Data
As of Aug 26
 +0.42 / +1.85%
Today’s Change
11.57
Today|||52-Week Range
116.75
-33.86%
Year-to-Date
Game On for Pfizer With $14 Billion Medivation Buyout (or, Why Pfizer's Buyout of Med...
Aug 26 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Medivation to Pfizer, Clovis Priority Review
Aug 24 / Zacks.com - Paid Partner Content
'Mad Money' Lightning Round: I Can't Recommend Gilead
Aug 26 / TheStreet.com - Paid Partner Content
Clovis (CLVS) Stock Up on FDA Priority Review for Rucaparib
Aug 24 / Zacks.com - Paid Partner Content
5 Companies That Should Consider Kicking Their CEOs to the Curb
Aug 25 / MotleyFool.com - Paid Partner Content
Here's a Reason Why Clovis Oncology (CLVS) Stock Climbed Today
Aug 23 / TheStreet.com - Paid Partner Content